Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
The Commission has published the number of submitted proposals for calls DIGITAL-2024-CLOUD-DATA-06 and DIGITAL-2024-ADVANCED-DIGITAL-06.
Submitted proposals per topic for DIGITAL-2024-CLOUD-DATA-06:
DIGITAL-2024-ADVANCED-DIGITAL-06
The number of proposal received under the call is: 11
2024-09-11
|
1 week ago |
Calls for expressions of interest: Hosting entities for AI factories |
2024-09-09
|
1 week ago |
Frequently Asked Questions about the Data Act |
2024-09-06
|
1 week ago |
Consultations on Digital Europe programme |
2024-09-03
|
2 weeks ago |
Second round of cascading calls: smart cities and communities |
2024-08-26
|
3 weeks ago |
Evaluation results DIGITAL-2024-AI-ACT-06 and DIGITAL-ECCC-2024-DEPLOY-NCC-06 |
2024-08-21
|
4 weeks ago |
Evaluation finalised for Digital Skills and Jobs Platform |
2024-08-01
|
1 month ago |
EU AI Act and AI Innovation Package |
2024-08-01
|
1 month ago |
Evaluation results: DIGITAL-2024-AI-06 |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.